v3.26.1
Schedule I - Statement of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
(Loss) profit for the year $ (177,112,000) $ 20,800,000 $ 98,478,000
Adjustments to reconcile net profit to net cash provided by operating activities:      
Income tax (benefit) expense 2,468,000 16,252,000 57,540,000
Depreciation and amortization 84,951,000 75,463,000 73,532,000
Finance costs 20,775,000 21,942,000 38,793,000
Exchange differences 23,886,000 (13,565,000) 7,551,000
Impairment (gain) loss 17,488,000 43,052,000 25,290,000
Changes in operating assets and liabilities:      
Decrease (increase) in trade receivables 13,414,000 22,765,000 80,766,000
(Decrease) increase in trade payables (28,682,000) (17,255,000) (70,573,000)
Other changes in operating assets and liabilities (51,659,000) (62,646,000) (23,457,000)
Income tax received (10,329,000) (15,799,000) (113,308,000)
Net cash provided by operating activities 51,464,000 243,258,000 178,372,000
Payments due to investments:      
Other intangible assets (1,556,000) (3,024,000) (2,787,000)
Net cash used in investing activities (73,132,000) (66,937,000) (81,806,000)
Cash flows from financing activities:      
Dividends paid (10,451,000) (9,758,000)  
Repayment of debt instruments (35,760,000) (147,624,000) (179,075,000)
Proceeds from debt instruments 50,244,000 10,255,000  
Payments for lease liabilities (16,185,000) (16,201,000) (14,967,000)
Payments to acquire own shares (4,691,000) (2,428,000)  
Interest paid (12,550,000) (26,192,000) (42,207,000)
Net cash used in financing activities 3,464,000 (175,508,000) (282,147,000)
Total net increase (decrease) in cash and cash equivalents (18,204,000) 813,000 (185,581,000)
Beginning balance of cash and cash equivalents 132,973,000 136,470,000  
Foreign exchange (losses) gains on cash and cash equivalents 7,920,000 (5,191,000) 287,000
Ending balance of cash and cash equivalents 122,812,000 132,973,000 136,470,000
Separate      
Cash flows from operating activities:      
(Loss) profit for the year (20,993,000) (18,507,000) 5,429,000
Adjustments to reconcile net profit to net cash provided by operating activities:      
Income tax (benefit) expense   (367,000) (115,000)
Depreciation and amortization 130,000 126,000 123,000
Finance income (253,000) (889,000) (31,982,000)
Finance costs 7,002,000 6,477,000 19,638,000
Exchange differences 2,161,000 (447,000) (86,000)
Impairment (gain) loss     (429,000)
Changes in operating assets and liabilities:      
Decrease (increase) in trade receivables 6,694,000 12,536,000 53,052,000
(Decrease) increase in trade payables 6,687,000 (14,191,000) (13,680,000)
Other changes in operating assets and liabilities (1,234,000) (215,000) (8,276,000)
Income tax received   367,000  
Net cash provided by operating activities 194,000 (15,110,000) 23,674,000
Payments due to investments:      
Loans to group companies     (3,250,000)
Proceeds from loans to group companies   51,709,000 120,510,000
Net cash used in investing activities   51,709,000 117,260,000
Cash flows from financing activities:      
Dividends paid (10,451,000) (9,758,000)  
Repayment of debt instruments (205,000)    
Proceeds from debt instruments 50,244,000 10,255,000  
Payments for debt issuance cost (35,760,000) (6,000)  
Payments for lease liabilities (158,000) (153,000) (149,000)
Proceeds from loans from group companies 18,171,000 40,947,000 6,770,000
Repayments of loans from group companies (16,492,000) (75,089,000) (147,882,000)
Payments to acquire own shares (4,691,000) (2,428,000)  
Interest paid (1,173,000)    
Net cash used in financing activities (515,000) (36,232,000) (141,261,000)
Total net increase (decrease) in cash and cash equivalents (321,000) 367,000 (327,000)
Beginning balance of cash and cash equivalents 614,000 227,000 605,000
Foreign exchange (losses) gains on cash and cash equivalents 205,000 20,000 (51,000)
Ending balance of cash and cash equivalents $ 498,000 $ 614,000 $ 227,000